← All organizations

Global Health Innovative Technology Fund

Academic/Hospital

Also known as: Global Fund | Global Health Innovative Technology Fund

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jul 25, 2023

Timeline

No events for the selected filters.

Drugs by trial phase (7 distinct, 5 trials)

Phase 4 (4 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

(+)-sj000557733

Phase 1 (1 own, 0 via acquisition)

anapn1

Other trials (1 own, 0 via acquisition)

multivitamins

Indications

Studied for

Malaria

Recent trials (5)

NCT05905432CollaboratorPhase 1Jul 25, 2023
NCT06076213CollaboratorPhase 4May 1, 2023
NCT04709692CollaboratorPhase 2Apr 14, 2021
NCT04041973CollaboratorN/AJul 31, 2019
NCT02661373CollaboratorPhase 1Mar 1, 2016

Details

Last known activity: Jul 25, 2023